Time to initiation of anti-tuberculosis treatment

被引:68
|
作者
Pirkis, JE
Speed, BR
Yung, AP
Dunt, DR
MacIntyre, CR
机构
[1] FAIRFIELD HOSP,FAIRFIELD,VIC 3078,AUSTRALIA
[2] AUSTRALIAN NATL UNIV,NATL CTR EPIDEMIOL & POPULAT HLTH,CANBERRA,ACT 2601,AUSTRALIA
[3] UNIV WESTERN AUSTRALIA,DEPT PUBL HLTH,NEDLANDS,WA 6009,AUSTRALIA
来源
TUBERCLE AND LUNG DISEASE | 1996年 / 77卷 / 05期
关键词
D O I
10.1016/S0962-8479(96)90111-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To examine delay in initiation of treatment for tuberculosis (TB). Design: Delay in the initiation of treatment for 142 notified TB patients was examined by a retrospective record review. Particular attention was given to the periods between (1) onset of symptoms and initiation of treatment, and (2) determination of sputum positivity and initiation of treatment. An expert panel nominated 30 days and 3 days as 'acceptable' periods for (1) and (2), respectively. Results: Only 31% of patients commenced treatment within 30 days of onset of symptoms. This was so for both sputum smear-positive and negative cases, and was not significantly related to the site of infection, referral source, age, gender or ethnicity of the patient. Of patients with smear-positive pulmonary TB, 86% received treatment within 3 days of this result being demonstrated. Those with a delay of greater than 3 days were all investigated by private doctors through private laboratories. Conclusion: There are appreciable delays in initiation of treatment for TB. Measures to combat these unacceptable delays are discussed.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [21] Monitoring changes in anti-tuberculosis treatment: associated factors determined at the time of diagnosis
    Altet, M. N.
    Vidal, R.
    Mila, C.
    Rodrigo, T.
    Casals, M.
    Mir, I.
    Ruiz-Manzano, J.
    Jimenez-Fuentes, M. A.
    Sanchez, F.
    Maldonado, J.
    Blanquer, R.
    de Souza-Galvaeo, M. L.
    Solsona, J.
    Azlor, E.
    Diaz, D.
    Calpe, J. L.
    Cayla, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (11) : 1435 - 1441
  • [22] ANTI-TUBERCULOSIS CHEMOTHERAPY
    JOHNSTON, RF
    AUDET, PR
    AMERICAN FAMILY PHYSICIAN, 1978, 17 (06) : 136 - 139
  • [23] Initiation of anti-tuberculosis treatment in children following gastric aspirate testing, Botswana, 2008-2012
    Lo, T. Q.
    Matlhare, L.
    Mugisha, K.
    Lere, T. D.
    Ho-Foster, A.
    Boyd, R.
    Cavanaugh, J.
    Ncube, R.
    Steenhoff, A. P.
    Arscott-Mills, T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (03) : 315 - +
  • [24] ANTI-TUBERCULOSIS VACCINES
    RANGANATHAN, KS
    BRITISH MEDICAL JOURNAL, 1959, 2 (NOV21): : 1101 - 1101
  • [25] MISDIAGNOSIS OF LUNG TUBERCULOSIS LEADS TO DELAYING IN LUNG CANCER DIAGNOSIS AND TREATMENT: TIME TO USE ANTI-TUBERCULOSIS TREATMENT JUDICIOUSLY
    Devgan, R. K.
    ANNALS OF ONCOLOGY, 2015, 26
  • [26] Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
    Shang, Penghui
    Xia, Yinyin
    Liu, Feiying
    Wang, Xiaomeng
    Yuan, Yanli
    Hu, Daiyu
    Tu, Dehua
    Chen, Yixin
    Deng, Peiyuan
    Cheng, Shiming
    Zhou, Lin
    Ma, Yu
    Zhu, Lizhen
    Gao, Weiwei
    Wang, Hongyuan
    Chen, Dafang
    Yang, Li
    He, Pingping
    Wu, Shanshan
    Tang, Shaowen
    Lv, Xiaozhen
    Shu, Zheng
    Zhang, Yuan
    Yang, Zhirong
    Chen, Yan
    Li, Na
    Sun, Feng
    Li, Xiaoting
    He, Yingjian
    Garner, Paul
    Zhan, Siyan
    PLOS ONE, 2011, 6 (07):
  • [27] Knowledge about anti-tuberculosis treatment among nurses at tuberculosis clinics
    Yukselturk, Neriman
    Dinc, Leyla
    INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2013, 19 (01) : 47 - 53
  • [28] Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis
    Laghari, Madeeha
    Talpur, Bandeh Ali
    Sulaiman, Syed Azhar Syed
    Khan, Amer Hayat
    Bhatti, Zohra
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2020, 9 (03) : 281 - 288
  • [29] A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity
    Yathursan, Sutharsana
    Wiles, Siouxsie
    Read, Hannah
    Sarojini, Vijayalekshmi
    JOURNAL OF PEPTIDE SCIENCE, 2019, 25 (11)
  • [30] PREDICTOR FACTORS TO POOR ADHERENCE TO ANTI-TUBERCULOSIS TREATMENT
    Kchouk, Hager
    Ben Mansour, Amani
    Ben Saad, Soumaya
    Daghfous, Hafaoua
    Tritar, Fatma
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58